DELUCCA JOHN 4

4 · ENDO PHARMACEUTICALS HOLDINGS INC · Filed Mar 14, 2012

Form 4

Period: 2012-03-12

Director

Transactions

Exercise/Conversion
Common Stock, par value, $.01 per share
2012-03-12+1,417→ 21,596 total
Award
2010 Stock Incentive Plan Restricted Stock Units (RSU)
2012-03-12+5,481→ 5,481 total
Exercise/Conversion
2007 Stock Incentive Plan Restricted Stock Units (RSU)
2012-03-12−1,417→ 0 total
From: 2012-03-12Exp: 2012-03-12→ Common Stock (1,417 underlying)

Footnotes (6)

[F1]Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of common stock of Endo Pharmaceuticals Holdings Inc.
[F2]These restricted stock units (RSUs) generally vest 100% on March 12, 2013. Upon vesting, we consider the underlying RSUs to be expired.
[F3]These securities were granted to Mr. Delucca in consideration of his services on the Endo Pharmaceuticals Holdings Inc. Board of Directors.
[F4]This represents vesting of restricted stock units granted to Mr. Delucca on March 12, 2010. Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of common stock of Endo Pharmaceuticals Holdings Inc.
[F5]This number represents (i) 5,481 restricted stock units (ii) 2,262 shares of restricted stock, all of which are fully vested and (iii) 13,853 shares of common stock. Mr. Delucca's beneficial ownership disclosed in this table excludes all shares held by Mr. Delucca indirectly, including shares underlying stock options.
[F6]Fifty percent (50%) of Mr. Delucca's March 12, 2010 grant of restricted stock units (RSUs) generally vest on each of March 12, 2011 and March 12, 2012. The 1,417 shown here is the amount that vested on March 12, 2012. Upon vesting, we consider the underlying RSUs to be expired.

Documents

2 files